Angiex, Inc.

Angiex makes TM4SF1-directed antibody-drug conjugates for the treatment of solid cancers.

[Angiex, Inc. @AngiexInc]

Angiex is delighted to be presenting at the 10th annual Global Family Office Investment Summit in Miami, March 24-25.

[Agilent Technologies @Agilent]

Agilent Awards Angiex with a Golden Ticket at LabCentral https://t.co/WjiHdTHZ3S

[MilliporeSigma @MilliporeSigma]

Happy to announce our collaboration with @AngiexInc to help accelerate #ADC therapy for #cancer: https://t.co/k4O4WDyZul

[Sigma-Aldrich @SigmaAldrich]

Happy to announce our collaboration with @AngiexInc to help accelerate #ADC therapy for #cancer: https://t.co/QdADpWAzbC

[Merck Life Science @Merck_lifesci]

Happy to announce our collaboration with @AngiexInc to help accelerate #ADC therapy for #cancer: https://t.co/BYYwXTvsz7

[LabCentral @LabCentral]

@Agilent #GoldenTicket Celebration in full swing. Pitches to follow from @LabCentral resident companies #CocoonBio @AngiexInc #Revitope #Mix #Mingle #learn #Biotech

[Johannes Fruehauf🇺🇦 @JFruehauf]

Sorry-I didn't hit "send" yesterday...
Congratulations to the #Goldenticket winner @AngiexInc: developing #cancer therapies through anti-angiogenesis. @pauljaminet expertly presenting. https://t.co/6FJ97QTM9M

[LabCentral @LabCentral]

https://t.co/dZVCwNefUm … @Agilent awards @AngiexInc with a Golden Ticket at @labCentral, congrats!

[Angiex, Inc. @AngiexInc]

Angiex, Inc. is a new biotechnology startup pioneering vascular therapy for cancer. Find us at https://t.co/OJZLri7w8n.